跳至主要内容
临床试验/CTRI/2024/06/068698
CTRI/2024/06/068698尚未招募4 期

A pilot study assessing the role of induction chemotherapy followed by chemo radiation in locally advanced cervical cancer in a tertiary care hospital in central rural India

Siddharth gupta memorial hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年6月15日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
progression free survival in FIGO stage III and IVa patient after giving NACT

研究概览

简要总结

After approval from the Institutional Ethics Committee, A pilot study will be conducted in MEDICAL ONCOLOGY and RADIATION ONCOLOGY Department of SGMCH unit of  department of Acharya Vinoba Bhave rural Hospital (AVBRH), a tertiary care teaching hospital situated in the rural area of  Wardha District, Maharashtra, India.

At first contact with the patient, a detailed history and clinical evaluation of the patient shall be done. Clinical examination and a biopsy from the cervical lesion shall be taken and any previous treatment will be ascertained.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • •Age more than 18 year ECOG 0/1 Good renal, hepatic and CBC Women with biopsy proven squamous, adeno or adenosquamous carcinoma Stage III and IVA FIGO (2018).

排除标准

  • •Patients with early stage cancer stage I and II metastaic disease at presentation autoimmune disease patient who not willing for study.

结局指标

主要结局

progression free survival in FIGO stage III and IVa patient after giving NACT

时间窗: progression free survival in FIGO stage IIIand IVa patient after giving NACT after 8week of completion of radiation

次要结局

  • progression free survival(At baseline)
  • radiation side effect compliance and tolerabilty(baseline)

研究者

发起方
Siddharth gupta memorial hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Kanchan Dasharthrao Devde

Datta Meghe Institute of higher education and research centre

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Comparison of Propofol and Etomidate used for general anaesthesia for Smooth I-gel Insertion: A Study Using BIS Monitoring(for depth of anaesthesia) during General Anesthesia
CTRI/2024/12/078128All India Institute Of Medical Sciences Department of Anaesthesiology60
招募中
3 期
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) induction and lenalidomide maintenance in patients with newly diagnosed multiple myeloma (GMMG-HD7)Multiple Myeloma
2024-513464-26-00Universitaetsklinikum Heidelberg AöR662
尚未招募
Phase 3 4
A study to test a new method of pain relief for patients being operated for esophageal cancer (cancer of foodpipe)Medical and Surgical, (2) ICD-10 Condition: K20-K31||Diseases of esophagus, stomach and duodenum, (3) ICD-10 Condition: C15-C26||Malignant neoplasms of digestive organs,
CTRI/2025/03/081913Tata Memorial Hospital40
尚未招募
4 期
Comparative study of lekhan basti in Sthoulya with special reference to obesityOverweight. Ayurveda Condition: MEDOROGAH,
CTRI/2024/09/074383Yashwant Ayurvedic College86
已完成
1 期
This is clinical study to test, for the first time in people, the safety (any good or bad effects), how long the drug can stay in the body and if it can control the disease of people diagnosed with advanced cancer that has not responded to treatment, has returned after it has been treated, or cannot be treated by surgery, drugs, or any other known treatments.Part C: advanced or unresectable STs (Spain only)Part B : r/r diffuse large B cell lymphoma (DLBCL) (Cohort 1), advanced basal cell carcinoma (BCC) (Cohort 2), r/r DLBCL under an alternative dosing regimen (Cohort 3)Part A: advanced or unresectable solid tumors (STs) and relapsed and/or refractory (r/r) advanced non-Hodgkin's lymphomas (NHLs)
2023-509969-20-00Celgene Corp.127